Abstract:Background: An ideal animal model to study SARS-coronavirus 2 (SARS-CoV-2) pathogenesis and evaluate therapies and vaccines should reproduce SARS-CoV-2 infection and recapitulate lung disease like those seen in humans. The angiotensin-converting enzyme 2 (ACE2) is a functional receptor for SARS-CoV-2, but mice are resistant to the infection because their ACE2 is incompatible with the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Methods: We generated a mouse-adapted strain SARS-CoV-2 by serial passages in the lung of BALB/c mice. Complete genome deep sequencing of different generations of viruses was performed to characterize the dynamics of the adaptive mutations in SARS-CoV-2. Indirect immunofluorescence analysis and Biolayer interferometry experiments demonstrated that two mutations in RBD significantly increased its binding affinity towards mouse ACE2. Significantly, TLR7/8 agonist Resiquimod block SARS-CoV-2 in vitro and in vivo. Findings: We adapted a wild-type SARS-CoV-2 by serial passages in the lung of BALB/c mice. The mouse-adapted strain WBP-1 showed increased infectivity in BALB/c mice and led to severe interstitial pneumonia. We characterized the dynamics of the adaptive mutations in SARS-CoV-2 and demonstrated that Q493K and Q498H in RBD significantly increased its binding affinity towards mouse ACE2. Additionally, The TLR7/8 agonist Resiquimod was able to protect mice against WBP-1 challenge, demonstrating this mouse-adapted strain is a useful tool to investigate COVID-19 and develop new therapies. Interpretation: We found for the first time that the Q493K and Q498H mutations in the RBD of WBP-1 enhanced its interactive affinities with mACE2. The mouse-adapted SARS-CoV-2 provides a valuable tool for the evaluation of novel antiviral and vaccine strategies, especially in determining the immunopathological consequences of any intervention. This study also verified the antiviral activity of TLR7/8 agonist Resiquimod against SARS-CoV-2 in vitro and in vivo.Funding Statement: This research was funded by Emergency Science and Technology Project of Hubei Province(2020FCA046)and Independent Science and Technology Innovation Fund of Huazhong Agricultural University in 2020 (2662020PY002).Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: The animal experiments were approved by the Research Ethics Committee, Huazhong Agricultural University, Hubei, China (HZAUMO-2020-0007). All the animal experiments were conducted in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals from the Research Ethics Committee, Huazhong Agricultural University, Hubei, China.

Diffuse alveolar lesion in BALB/c mice induced with human reovirus BYD1 strain and its potential relation with SARS.

[Airway Inflammation Induced by Poly(I:C) Stimulation in the Late Stage of Respiratory Syncytial Virus Infection in Mice and Its Mechanism].

Experimental Infection of Macaques with the Human Reovirus BYD1 Strain: an Animal Model for the Study of the Severe Acute Respiratory Syndrome

Reovirus, Isolated from SARS Patients

Pathology Of Guinea Pigs Experimentally Infected With A Novel Reovirus And Coronavirus Isolated From Sars Patients

Pathological Changes and Pathogenesis of Experimental Infection of Cynomolgus Monkeys with Reovirus Strain BYD1

Viral Replication and Lung Lesions in BALB/c Mice Experimentally Inoculated with Avian Metapneumovirus Subgroup C Isolated from Chickens.

Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus

Acute Respiratory Distress Syndrome Induced by H9N2 Virus in Mice

Organ Distribution of Severe Acute Respiratory Syndrome (SARS) Associated Coronavirus (sars‐cov) in SARS Patients: Implications for Pathogenesis and Virus Transmission Pathways

Effects of respiratory syncytial virus(RSV) infection on the airway hyperresponesivenesss of ovabumin(OVA)-sensitized Balb/C mice

Toll-Like Receptor Agonist R848 Protects Mice from Lethal SARS-CoV-2 Infections

The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus

[Comparison of Respiratory Syncytial Virus Infection on Different Week-ages BALB/c Mice].

Respiratory Syncytial Virus Infection in Immunocompetent and Immunocompromised Murine

Aggravated Airway Inflammation and Resistance in a Respiratory Syncytial Virus Infected Murine Asthma Model

Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice.

A Novel Potentially Recombinant Rodent Coronavirus with a Polybasic Cleavage Site in the Spike Protein

Bat mammalian orthoreoviruses cause severe pneumonia in mice

PATHOGENICITY OF REASSORTANT CANINE INFLUENZA VIRUS WITH PANDEMIC/2009 IN MICE

Respiratory Syncytial Virus Infection Differentiates Airway Dysfunction in the Central and Peripheral Airways in Ova-Sensitized Mice